Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to &lt;90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], &gt;300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of &lt;15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P&lt;0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P&lt;0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

Corrosion Behavior of Titanium Alloys (Ti CP2, Ti-6Al-2Sn-4Zr-2Mo, Ti-6Al-4V and Ti Beta-C) with Anodized and Exposed in NaCl and H₂SO₄ Solutions

Nowadays, different industries, such as the aerospace and biomedical industries, prefer using Ti alloys due to their excellent anti-corrosion properties and ability to generate a TiO2 oxide layer; this induces the use of anodization to increase the useful life of components. The aim of this work is to characterize the electrochemical effect of anodizing treatment on titanium alloys (Ti CP2, Ti-6Al-2Sn-4Zr-2Mo, Ti-6Al-4V, and Ti Beta-C) in NaOH and KOH at 1 M, applying a current density of 0.0025 A/cm2. The electrochemical techniques employed were electrochemical noise (EN) and electrochemical impedance spectroscopy (EIS), supported by ASTM G199 and ASTM G106 in electrolytes of NaCl and H2SO4 at 3.5 wt. % as a simulation of marine and industrial atmospheres. Also, the anodized transversal section and surface morphology were characterized by a scanning electron microscope (SEM). The results of both electrochemical techniques indicated that Ti-6Al-2Sn-4Zr-2Mo anodized in NaOH presented the best properties against corrosion, and the thickness of the oxide was the biggest

XIII Jornada de Investigación 2022

Los desafíos en las dinámicas económicas, sociales, políticas y psicológicas han puesto de relieve la importancia de involucrar en la enseñanza universitaria actividades que conecten a los estudiantes con las realidades del contexto en el que se desarrollan; simultáneamente, hoy más que nunca se hace evidente que la ciencia, la tecnología y la innovación (CTI) son cruciales para atender los retos sociales, ambientales y económicos de las sociedades actuales. En este contexto, la Jornada de Investigación de la Universidad Católica de Colombia es quizás uno de los espacios institucionales más emblemáticos en el que se visibilizan las actividades en CTI de estudiantes, jóvenes investigadores y profesores, que buscan contribuir a la solución de problemáticas relevantes del entorno. En esta oportunidad, aproximadamente 177 autores y más de 250 espectadores se dieron cita en un escenario virtual que permitió el intercambio de saberes y conocimientos en torno a muchos temas con un lenguaje común: el bienestar de la humanidad y la respuesta efectiva a los retos que tenemos como comunidad. Esta cuarta versión de las Memorias compila las ponencias presentadas en la XIII Jornada de Investigación de 2022, enmarcadas en los tres ejes temáticos de investigación que tiene la Universidad Católica de Colombia: i) Derecho, Cultura y Sociedad, ii) Desarrollo Humano y Sostenible, y iii) Gestión de la Tecnología al Servicio de la Sociedad. Desde la Dirección Central de Investigaciones nos encontramos profundamente agradecidos con todos y cada uno de los participantes, y nos sentimos aún más orgullosos por la calidad de los trabajos presentados. Sea esta la oportunidad para hacer extensiva una felicitación a los autores y a las diferentes Unidades Académicas que, con su compromiso e invaluable labor, permitieron que este evento se desarrollara con éxito.Persona, hospitalidad y construcción de comunidad desde la fraternidad. José Martí: acerca de la libertad en la condición humana. Moda, imagen y alimentación: una tríada para el bien y para el mal. Lecciones de la pandemia de covid-19: conflictos entre la protección jurídica de las patentes farmacéuticas y el interés general de la salud pública. Psicología y sexualidad: propuesta para la formación de psicólogos colombianos. Estrategias para el desarrollo de herramientas que fomentan el aprendizaje para el reconocimiento y la apropiación del patrimonio cultural. Análisis descriptivo de relatos honestos y deshonestos por medio del sistema de evaluación global. El uso de la herramienta LIWC para el estudio de relatos altruistas y prosociales. ¿De qué manera influyen las redes sociales como medio de información en campañas políticas?. Sistema de Seguridad Social en Colombia: una crisis deficitaria que se refuerza con el tiempo. Turismo sexual en menores de edad: problemática endémica en el territorio colombiano. Transgresión de los derechos humanos en relación con los asesinatos de líderes sociales en el Estado colombiano. El nuevo escenario para la procedencia de la eutanasia en Colombia: una mirada desde los derechos humanos. Protección de los derechos de la infancia frente a los grupos al margen de la ley. El derecho a un nivel de vida adecuado: un enfoque hacia el desplazamiento forzado de los pueblos indígenas. Tráfico de órganos humanos: delito transnacional que vulnera los derechos humanos y su regulación en el marco jurídico colombiano. Transgresión de los derechos a la vida y la libertad en el sistema penitenciario como consecuencia de la violencia social. Acceso a la justicia colombiana en tiempos de SARS-CoV-2. Prioridades para la administración de justicia penal en Colombia: ¿balanceando espectáculo e indicadores de eficacia? Desarrollo de competencias para la investigación en neuropsicología: experiencia del semillero experimental. La dificultad al ingreso de los centros geriátricos. Principio de realidad sobre la formalidad constitucional en contrato verbal laboral en un satélite del Consultorio Jurídico de la Universidad Católica de Colombia. La pena de muerte en colisión con los derechos fundamentales. Maternidad subrogada: objetificación y vulneración de los derechos de la mujer. Una dieta inconsciente hacia el vegetarianismo. Sistema de evaluación del bienestar gerontológico para un diseño arquitectónico sostenible. Caso de estudio: hogar de paso San Francisco de Asís, Villavicencio, Meta. Revisión sistemática interacción líder-colaborador: futuras investigaciones. Análisis conceptual del talento académico desde los modelos teóricos que lo sustentan. Identificación de potenciales factores de riesgo suicida: una mirada contextual. La regulación emocional en tiempos de coronavirus. GEES: Guía de Evaluación de Edificaciones Sostenibles, vivienda de interés social, clima cálido húmedo. Estructura proyectual y sostenible para el diseño y desarrollo de un modelo de vivienda de madera en San Andrés y Providencia, Colombia. Innovación social para la gestión territorial. Construcción de material didáctico para el entrenamiento en habilidades de regulación emocional e interpersonales dirigidas a poblaciones expuestas a situaciones de violencia política. Alternativas sostenibles de modelos de desarrollo industrial. La ruralidad dentro de los procesos del desarrollo local en Usme. Se ha dejado de dibujar arquitectura con las manos. Calidad de vida, bienestar y felicidad en el trabajo: una revisión sistemática de la literatura científica, 2011-2021. Autonomía, autorregulación y educación moral: reflexiones desde la psicología del desarrollo moral. Características de los niños, niñas y adolescentes expuestos a contextos de conflicto armado en Colombia. Revisión bibliométrica de artículos sobre la crianza en niños, niñas y adolescentes colombianos. Narrativas sociales en el proceso de cualificación de lo público La habitación exterior como extensión de la vivienda. Utilización de nanopartículas magnéticas Fe3O4 y ozono para la degradación/eliminación de azul de metileno en agua residual textil. Estudio paramétrico de un modelo numérico Fem de un ensayo CBR. ¿Cómo construir identidad de manera incluyente a partir del reconocimiento de patrimonio cultural construido?. Veracidad de los resultados del ensayo de penetración dinámica de CONO(PDC). Análisis de texto a partir del procesamiento de lenguaje natural para identificar sintomatología depresiva en redes sociales. Análisis de texto para la detección de depresión en comentarios de usuarios de la red social Instagram. Diseño y desarrollo de un videojuego para evaluar la interacción de las redes atencionales en la sintomatología depresiva. Herramienta tecnológica para el apoyo en la detección de sintomatología ansiosa en jóvenes. Optimización del despliegue de aplicaciones web a partir de computación en nube sin servidor. Prototipo alfa de un videojuego serio para el apoyo en la detección de sintomatología depresiva en adultos jóvenes. La importancia de la visualización de datos en la era del Big Data y sus herramientas. Prototipo de sensor para el registro electroencefalográfico. Prototipo de un algoritmo basado en inteligencia artificial para el apoyo a especialistas en el diagnóstico del Alzheimer. Evaluación posocupacional del confort térmico en la vivienda social: análisis de una revisión sistemática prisma desde el diseño resiliente. Inteligencia artificial, problema u oportunidad para el Derecho. Impacto en el empleo en relación con las TIC y la inteligencia artificial. Neuroprivacidad. El test de asociación implícita, un paradigma que permite abordar nuestras actitudes inconscientes. ¿Cuál es el límite del uso de las tecnologías frente al derecho de información y de la libre expresión?. Tendencias de fijación de precios basados en el valor: un análisis desde la minería de datos. Recorrido virtual de la Universidad Católica de Colombia Sede Claustro para la inducción de estudiantes y docentes. Introducción a la bioarquitectura del paisaje, cartilla Paisaje, ambiente y tecnología. Descripción plan piloto (Choachí). Caracterización de las habilidades específicas para el reconocimiento del patrimonio cultural – Borde urbano sur oriental de Bogotá. Videojuego para estimular la memoria episódica en pacientes con deterioro cognitivo leve: validación de contenido. CONCLUSIONESTercera edició

Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

Background: In early 2020, COVID-19 massively hit Italy, earlier and harder than any other European country. This caused a series of strict containment measures, aimed at blocking the spread of the pandemic. Healthcare delivery was also affected when resources were diverted towards care of COVID-19 patients, including intensive care wards. Aim of the study: The aim is assessing the impact of COVID-19 on cardiac imaging in Italy, compare to the Rest of Europe (RoE) and the World (RoW). Methods: A global survey was conducted in May–June 2020 worldwide, through a questionnaire distributed online. The survey covered three periods: March and April 2020, and March 2019. Data from 52 Italian centres, a subset of the 909 participating centres from 108 countries, were analyzed. Results: In Italy, volumes decreased by 67% in March 2020, compared to March 2019, as opposed to a significantly lower decrease (p &lt; 0.001) in RoE and RoW (41% and 40%, respectively). A further decrease from March 2020 to April 2020 summed up to 76% for the North, 77% for the Centre and 86% for the South. When compared to the RoE and RoW, this further decrease from March 2020 to April 2020 in Italy was significantly less (p = 0.005), most likely reflecting the earlier effects of the containment measures in Italy, taken earlier than anywhere else in the West. Conclusions: The COVID-19 pandemic massively hit Italy and caused a disruption of healthcare services, including cardiac imaging studies. This raises concern about the medium- and long-term consequences for the high number of patients who were denied timely diagnoses and the subsequent lifesaving therapies and procedures

International Impact of COVID-19 on the Diagnosis of Heart Disease

Background: The coronavirus disease 2019 (COVID-19) pandemic has adversely affected diagnosis and treatment of noncommunicable diseases. Its effects on delivery of diagnostic care for cardiovascular disease, which remains the leading cause of death worldwide, have not been quantified. Objectives: The study sought to assess COVID-19's impact on global cardiovascular diagnostic procedural volumes and safety practices. Methods: The International Atomic Energy Agency conducted a worldwide survey assessing alterations in cardiovascular procedure volumes and safety practices resulting from COVID-19. Noninvasive and invasive cardiac testing volumes were obtained from participating sites for March and April 2020 and compared with those from March 2019. Availability of personal protective equipment and pandemic-related testing practice changes were ascertained. Results: Surveys were submitted from 909 inpatient and outpatient centers performing cardiac diagnostic procedures, in 108 countries. Procedure volumes decreased 42% from March 2019 to March 2020, and 64% from March 2019 to April 2020. Transthoracic echocardiography decreased by 59%, transesophageal echocardiography 76%, and stress tests 78%, which varied between stress modalities. Coronary angiography (invasive or computed tomography) decreased 55% (p &lt; 0.001 for each procedure). In multivariable regression, significantly greater reduction in procedures occurred for centers in countries with lower gross domestic product. Location in a low-income and lower–middle-income country was associated with an additional 22% reduction in cardiac procedures and less availability of personal protective equipment and telehealth. Conclusions: COVID-19 was associated with a significant and abrupt reduction in cardiovascular diagnostic testing across the globe, especially affecting the world's economically challenged. Further study of cardiovascular outcomes and COVID-19–related changes in care delivery is warranted

Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

Objectives: The INCAPS COVID Oceania study aimed to assess the impact caused by the COVID-19 pandemic on cardiac procedure volume provided in the Oceania region. Methods: A retrospective survey was performed comparing procedure volumes within March 2019 (pre-COVID-19) with April 2020 (during first wave of COVID-19 pandemic). Sixty-three (63) health care facilities within Oceania that perform cardiac diagnostic procedures were surveyed, including a mixture of metropolitan and regional, hospital and outpatient, public and private sites, and 846 facilities outside of Oceania. The percentage change in procedure volume was measured between March 2019 and April 2020, compared by test type and by facility. Results: In Oceania, the total cardiac diagnostic procedure volume was reduced by 52.2% from March 2019 to April 2020, compared to a reduction of 75.9% seen in the rest of the world (p&lt;0.001). Within Oceania sites, this reduction varied significantly between procedure types, but not between types of health care facility. All procedure types (other than stress cardiac magnetic resonance [CMR] and positron emission tomography [PET]) saw significant reductions in volume over this time period (p&lt;0.001). In Oceania, transthoracic echocardiography (TTE) decreased by 51.6%, transoesophageal echocardiography (TOE) by 74.0%, and stress tests by 65% overall, which was more pronounced for stress electrocardiograph (ECG) (81.8%) and stress echocardiography (76.7%) compared to stress single-photon emission computerised tomography (SPECT) (44.3%). Invasive coronary angiography decreased by 36.7% in Oceania. Conclusion: A significant reduction in cardiac diagnostic procedure volume was seen across all facility types in Oceania and was likely a function of recommendations from cardiac societies and directives from government to minimise spread of COVID-19 amongst patients and staff. Longer term evaluation is important to assess for negative patient outcomes which may relate to deferral of usual models of care within cardiology

Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries

Background Anastomotic leak affects 8 per cent of patients after right colectomy with a 10-fold increased risk of postoperative death. The EAGLE study aimed to develop and test whether an international, standardized quality improvement intervention could reduce anastomotic leaks. Methods The internationally intended protocol, iteratively co-developed by a multistage Delphi process, comprised an online educational module introducing risk stratification, an intraoperative checklist, and harmonized surgical techniques. Clusters (hospital teams) were randomized to one of three arms with varied sequences of intervention/data collection by a derived stepped-wedge batch design (at least 18 hospital teams per batch). Patients were blinded to the study allocation. Low- and middle-income country enrolment was encouraged. The primary outcome (assessed by intention to treat) was anastomotic leak rate, and subgroup analyses by module completion (at least 80 per cent of surgeons, high engagement; less than 50 per cent, low engagement) were preplanned. Results A total 355 hospital teams registered, with 332 from 64 countries (39.2 per cent low and middle income) included in the final analysis. The online modules were completed by half of the surgeons (2143 of 4411). The primary analysis included 3039 of the 3268 patients recruited (206 patients had no anastomosis and 23 were lost to follow-up), with anastomotic leaks arising before and after the intervention in 10.1 and 9.6 per cent respectively (adjusted OR 0.87, 95 per cent c.i. 0.59 to 1.30; P = 0.498). The proportion of surgeons completing the educational modules was an influence: the leak rate decreased from 12.2 per cent (61 of 500) before intervention to 5.1 per cent (24 of 473) after intervention in high-engagement centres (adjusted OR 0.36, 0.20 to 0.64; P &lt; 0.001), but this was not observed in low-engagement hospitals (8.3 per cent (59 of 714) and 13.8 per cent (61 of 443) respectively; adjusted OR 2.09, 1.31 to 3.31). Conclusion Completion of globally available digital training by engaged teams can alter anastomotic leak rates. Registration number: NCT04270721 (http://www.clinicaltrials.gov)